Role of glycogen synthase kinase-3β signal molecule in myocardial hypertropy / 中国病理生理杂志
Chinese Journal of Pathophysiology
; (12): 601-604, 2010.
Article
em Zh
| WPRIM
| ID: wpr-403075
Biblioteca responsável:
WPRO
ABSTRACT
Glycogen synthase kinase-3β (GSK-3β) is a serine/threonine protein kinase, which takes part not only in glycogen metabolism, but also in cell proliferation, differentiation and apoptosis. GSK-3β is inhibited by growth factors and hypertrophic stimuli through phosphorylation of its N-terminal end serine (Ser9) residue. It is also activated by phosphorylation of its tyrosine (Tyr216) residue. GSK-3β is profoundly inactivated in mice with hypertrophic cardiomyopathy (HCM) and plays a secondary role in myosin heavy chain mutation. However, the role of GSK-3β in HCM was controversial. Recent studies have demonstrated that the activation of GSK-3β inhibits the myocardial hypertrophy, and is regulated by Wnt/Frizzld and PI3-K/Akt signaling pathways. This article introduces the molecular role of glycogen synthase kinase-3β signaling in myocardial hypertrophy and the different pathways on the activity of glycogen synthase kinase-3β (GSK-3β)
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Pathophysiology
Ano de publicação:
2010
Tipo de documento:
Article